Search research articles
Contact Us
Filters
Showing results (301-310 of 385) with videos related to
Page
of 39
Sort By:
Future Oncology (London, England)
|
February 19, 2016
Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients
Guangming Tian, Xinliang Zhao, Jun Nie, et al.
Talanta
|
May 18, 2023
Temperature-boosted PAM-less activation of CRISPR-Cas12a combined with selective inhibitors enhances detection of SNVs with VAFs below 0.01
Kena Chen, Ling Dai, Jie Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 11, 2021
Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study
Ya-Nan Jin, Ji-Jin Yao, Ya-Fei You, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 27, 2013
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
Xiao-qin Zhao, Chun-ling Dai, Shinobu Ohnuma, et al.
Thoracic Cancer
|
June 12, 2019
Salvage treatment with anlotinib for advanced non-small cell lung cancer
Di Wu, Jun Nie, Ling Dai, et al.
Frontiers in Oncology
|
March 22, 2021
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China
Xiaoling Chen, Jun Nie, Ling Dai, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
September 1, 2021
[Analysis of status quo of outcome indicators of randomized controlled trials in treatment of acute ischemic stroke with acupuncture in recent three years]
Ling-Ling Dai, Zhen-Min Xu, Xiao Liang, et al.
International Journal of Cancer
|
June 20, 2020
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer
Di Wu, Jun Nie, Weiheng Hu, et al.
ACS Applied Materials & Interfaces
|
May 21, 2015
Rational Design and Facial Synthesis of Li3V2(PO4)3@C Nanocomposites Using Carbon with Different Dimensions for Ultrahigh-Rate Lithium-Ion Batteries
Wen-feng Mao, Yan-bao Fu, Hui Zhao, et al.
Annals of Palliative Medicine
|
August 6, 2021
Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score-matched cohort study
Xiaoling Chen, Jun Nie, Ling Dai, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 385) with videos related to
Sort By:
Page
of 39
Future Oncology (London, England)
|
February 19, 2016
Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients
Guangming Tian, Xinliang Zhao, Jun Nie, et al.
Talanta
|
May 18, 2023
Temperature-boosted PAM-less activation of CRISPR-Cas12a combined with selective inhibitors enhances detection of SNVs with VAFs below 0.01
Kena Chen, Ling Dai, Jie Zhao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 11, 2021
Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study
Ya-Nan Jin, Ji-Jin Yao, Ya-Fei You, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 27, 2013
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2
Xiao-qin Zhao, Chun-ling Dai, Shinobu Ohnuma, et al.
Thoracic Cancer
|
June 12, 2019
Salvage treatment with anlotinib for advanced non-small cell lung cancer
Di Wu, Jun Nie, Ling Dai, et al.
Frontiers in Oncology
|
March 22, 2021
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China
Xiaoling Chen, Jun Nie, Ling Dai, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
September 1, 2021
[Analysis of status quo of outcome indicators of randomized controlled trials in treatment of acute ischemic stroke with acupuncture in recent three years]
Ling-Ling Dai, Zhen-Min Xu, Xiao Liang, et al.
International Journal of Cancer
|
June 20, 2020
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer
Di Wu, Jun Nie, Weiheng Hu, et al.
ACS Applied Materials & Interfaces
|
May 21, 2015
Rational Design and Facial Synthesis of Li3V2(PO4)3@C Nanocomposites Using Carbon with Different Dimensions for Ultrahigh-Rate Lithium-Ion Batteries
Wen-feng Mao, Yan-bao Fu, Hui Zhao, et al.
Annals of Palliative Medicine
|
August 6, 2021
Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score-matched cohort study
Xiaoling Chen, Jun Nie, Ling Dai, et al.
Page
of 39